µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© ^)C$8:@
P5
<85t
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© g1hg`qBBW
1¡¢Co-stimulators (or co-stimulating molecules) 2\z`G
2¡¢NK-kB ,h^;~|GT
3¡¢Immunoglobulin superfamily AP?{N:+
4¡¢antigen-presenting cell (APC) zhR_qW+
5¡¢death domain y?R <g^A
6¡¢CCR and CXCR +}G>M=t::
7¡¢Lectin (or mitogen) *2m&?,nJ
8¡¢Clusters of differentiation, CD) %.6?\w1e
9¡¢B7 family ("P mB?20
10¡¢Cytotoxic T lymphocyte, CTL) On96N|
11¡¢IL-15 and IL-15 receptor (IL-15R) 8w@W8(3B
12¡¢MHC restriction C)3$";$5)
13¡¢Affinity-chromatography 82@;.%
14¡¢Cyctosprin A, CsA {;z
L[AgCg
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC)
B|q3;P
<GFB'`L
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© n5,Pq+[
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 hk$nlc|$
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ %ucmJ-<y#
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ }yC,uEV
+KwF
U
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© >0;"qT
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ r;6YCI=z
ѪҺ²¡Ñ§×¨Òµ£º VV}fW"_ND
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿